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Airway histopathological changes in cystic fibrosis (CF) include damage to the epithelial tissue and accumulation of 
polymorphonuclear leukocytes (PMN). Airways of CF patients are usually colonized with bacteria such as mucoid 
Pseudomonas aeruginosa (PA). Bacteria and PMN can both release proteolytic enzymes capable of causing tissue 
damage. This study aims to clarify and compare the roles of these agents in epithelium damage. 
Epithelial cell (EC) damage and detachment induced by sputum samples from CF or non-CF patients, with and 
without lung infection, were assessed on amnionic EC in an in vitro model of airway epithelium. Protease activity 
was determined using inhibitor profiles, and compared to the proteolytic activity of isolated neutrophils and 
bacteria. 
Sputa from CF patients and infected non-CF patients induced high levels of detachment. PA also induced high 
levels of EC detachment but Staphylococcus aureus and Haemophilus influenzae, two other bacteria commonly 
isolated from CF sputa, induced no detachment. Antiprotease inhibition profiles were similar for PMN and 
sputa-induced EC detachment, but different for PA-induced detachment. 
These results suggest that PMN proteolytic enzymes, probably elastase and cathepsin G, are more likely to be the 
inducers of tissue damage in the airways of CF patients than PA proteolytic enzymes. 
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Introduction 
Progressive respiratory disease is the major cause of 
morbidity and mortality in cystic fibrosis (CF) (1). The 
respiratory disease is characterized by secretion of 
abnormal mucus, chronic bacterial infection and airway 
inflammation which results in destruction of airways and 
parenchyma (2). The most common bacterial organisms 
associated with this inflammation are Pseudomonas 
aeruginosa (PA), Staphylococcus aureus (SA) and 
Haemophilus influenzae (HI) (3). The histopathological 
features of airway inflammation include polymorpho- 
nuclear cellular infiltration, squamous metaplasia, loss of 
cilia and destruction of connective tissue. The current 
hypothesis is that the inflammatory response to infection 
leads to lung destruction, but the mechanisms and media- 
tors are not defined. However, it is likely that proteases, 
derived from either PA or from polymorphonuclear 
leukocytes (PMN) are responsible for some of the tissue 
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damage (4). PA-derived proteolytic enzymes include a 
metalloprotein elastase (4); PMN can release a number of 
tissue-damaging molecules, including oxygen radicals and 
proteases such as human leukocyte elastase (HLE) and 
cathepsin G (5). 
Previous studies have assessed the proteolytic activity of 
granulocytes and sputum samples in vitro using substrates 
and inhibitors (6), and whilst this has been valuable in 
terms of understanding which proteases are present, these 
approaches do not reflect the in vivo situation where intact 
epithelia such as human airway epithelium exhibit complex 
cellular attachments, both intercellular and to structural 
molecules of the basement membrane (BM) (7). The use of 
cultured cells attached to plastic has also contributed 
information relating to protease and cell interactions (8), 
but cultured cells are clearly different from native epithelial 
cells (EC) in terms of their states of differentiation, their 
susceptibility to damage and their attachment mechanisms 
(9,10), and thus may not reflect in vivo processes accurately. 
The present authors have developed a model which utilizes 
fresh human amnionic EC attached as an epithelial mono- 
layer to in vivo generated native BM. These cells exhibit 
similar features to airway cells, including tight junction 
formation and attachment to underlying BM via laminin, 
fibronectin and collagen type IV (9). This model, which has 
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now been utilized in a number of studies of EC damage 
(l&12), allows accurate quantification of cellular damage 
and detachment of EC as a direct measure of tissue 
damage (9). In this study of the proteolytic processes in CF, 
the effects of relevant bacteria, sputum samples and blood 
PMN from CF patients were compared with non-CF 
specimens for their capacity to induce EC damage and/or 
detachment in a human amnionic EC model. 
Materials and Methods 
STUDY SUBJECTS 
Sputum was collected in sterile containers from seven CF 
patients (six males and one female) with ages ranging from 
23 to 33 years (average 27.7 years). All had infective 
exacerbations with PA. To determine whether sputum- 
induced EC detachment was a feature of CF sputum only, 
of any infected (PMN-containing) sputum or of sputum in 
general, infected sputa from six patients with conditions 
other than CF were included as well as sputa from six 
patients with no infections. The non-CFlinfected group 
comprised of six males with age ranging from 32-82 years 
(average 65.5 years). Four had chronic airflow limitation 
with confirmed infective exacerbations (three with HI and 
one with PA). One patient had malignant mesothelioma and 
a Moraxella catarrhalis infection, and one had bronchiecta- 
sis with SA and PA infection. All had sputa containing 
many leukocytes. The third group of patients, classified as 
non-CF/non infected, consisted of three males and three 
females with an age range of 39-87 years (average 71 years); 
three had chronic airflow limitation, one had acute asthma, 
one had fibrosing alveolitis and one had chronic lym- 
phocytic leukaemia. None had any evidence of infection, 
and one sputum sample contained no leukocytes, three con- 
tained few leukocytes and two contained many leukocytes. 
STUDY DESIGN 
In this study, three types of sputa [CF sputa (all with 
infective exacerbations of PA), sputa from non-CF patients 
but with infective exacerbations (including PA, HI and SA) 
and sputa from non-CF patients (with no infections)], were 
compared with isolated blood neutrophils (both from CF 
and non-CF patients), as well as pure isolates of PA, HI 
and SA, for their ability to damage and/or detach EC. EC 
damage was measured using a 51Cr release assay while 
detachment of EC was scored visually. Finally, each vari- 
able was subjected to a panel of pre-defined protease 
inhibitors, and the pattern of inhibition was used to ‘finger- 
print’ the agents present in CF sputum which are likely to 
be responsible for EC disturbances. 
METHODS 
Preparation of Amnionic Membrane 
All studies were performed on amnionic membranes 
obtained at normal delivery and isolated from term 
placentae, as described previously (9). Briefly, term 
placentae were obtained fresh from the King Edward 
Memorial Hospital for Women (Perth, Australia) within 
4 h of delivery, and the amnion was separated from the 
chorion. Mucous and blood clots were removed from the 
stromal side of the amnion, and the membrane was washed 
extensively in phosphate-buffered saline (PBS). The washed 
membrane was then stretched on a glass microscope slide 
with the EC facing upward. Viability at this stage was 
routinely greater than 90% (trypan blue exclusion). The 
slide was then installed in a microchemotaxis chamber 
(Neuroprobe@, Cabin John, MD, U.S.A.) which afforded 
48 wells for experimentation. All assays were commenced 
within 1 h of obtaining the placenta. 
Spufa Collection and Assessment 
Sputum aliquots were diluted in Gey’s medium (NaCl= 
137 mm01 l- i; KCI=0.35 mmol l- ‘; CaCI,.2H,O = 
0.1 mmol l- I; MgCl,*6H,O=0.21 mmoll-‘; Na,HPO,= 
0.8 mm01 - ‘; KH,PO,= 1.8 mm01 1~ i; D-Glucose= 
55.5 mmol l- ‘; NaHCO, = 3.6 mmol 1~ ‘) and homogen- 
ized using a hand-held homogenizer (Tissue-Tearor, 
Biospec Products, Bartlesville, OK, U.S.A.) at 30 000 rpm 
for 10-15 s. The resulting solutions were assessed for total 
protein contents (Benzethonium Chloride turbidometric 
method; detection range lOO-32OOpg ml - ‘) (13). Stock 
solutions were generated by adjusting the protein concen- 
tration to 1 mg ml- r of Gey’s medium, and each sample 
was tested for its ability to detach EC as described below. 
Dose-response curves were generated in a separate exper- 
iment by testing log dilutions of the stock solutions at 100, 
10 and 1 pug/ml-‘. 
Preparation of Bacterial Samples 
To determine which component of the infected sputum 
samples was responsible for the EC detachment observed, 
bacteria and PMN (see below) were tested separately in this 
system. Strains of PA (mucoid strain) and SA were plated 
onto blood agar plates, while HI was plated onto chocolate 
agar. Plates were incubated overnight at 37°C. Colonies 
were scraped off the plates and placed in Gey’s medium. 
All suspensions were homogenized using a hand-held 
homogenizer at 30 000 rpm for lo-15 s. The resulting solu- 
tions were adjusted and assessed as described for the 
sputum samples. Samples of PA were plated following 
homogenization and were able to colonize. 
Preparafion of PMN 
PMN were isolated from peripheral blood of the seven 
patients and from seven volunteers (five males and two 
females, average age 27.8 years, ranging from 21-36) as 
follows: whole blood was layered in 3 ml aliquots on 
two-step Percoll gradients, densities 1.096 and 
1.084 g ml - ‘. Cellular bands containing >98% PMN were 
obtained at the 1.084/1.096 interface after centrifugation at 
350 g for 30 min (room temperature). Viability was always 
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greater than 98% as determined by trypan blue exclusion. 
The bands were pooled, and the cells were washed once in 
CA”- and Mg+’ -free NaCl, resuspended in Gey’s 
medium (osmolarity 285 mmol l- ‘) to 5 x 106, and 
10 x lo6 PMN ml- ‘. The cell suspensions were then added 
to the wells of the chamber containing the EC labelled 
with 51-sodium chromate (5’Cr, see below) at the rate of 
40 ~1 well ~ ’ in the presence or absence of 100 ng ml - ’ of 
12-O-tetradeconoyl phorbol-13-acetate (TPA). Chambers 
were incubated overnight in a 5% CO,/95% air incubator 
at 37”C, after which time both ‘lCr release (damage) and 
percentage detachment were assessed. Some samples were 
homogenized as for the sputum samples and showed a 
slight decrease in PMN viability from 98 to 96.5% by 
trypan blue exclusion. 
51Cr Release Assay of Epithelial Cell Damage 
To the wells of the chamber containing the amnionic EC, a 
5’Cr solution (Amersham Australia, North Ryde, Sydney, 
Australia) of 100 ,Ki ml - ’ of Gey’s medium was added at 
the rate of 40~1 well- ’ (4&i) and incubated for 1 h at 
37°C to allow EC to take up 5’Cr. The wells were then 
washed vigorously with PBS to wash off any excess 5’Cr. 
Following incubation with test samples at 37°C in 5% 
CO,/95% air, half of the contents of each well (20~1) was 
spun (2000 rpm, 5 min) and the supernatant was counted 
in a Hewlett-Packard gamma counter. Maximum release 
was achieved using papain (Sigma Chemical Company, 
St Louis, MO, U.S.A.; P-3375) dissolved in Gey’s medium 
at the rate of 500 BAEE ml-‘, a concentration which 
dissolves the membrane. Minimum or background 5’Cr 
release was the amount released when Gey’s medium alone 
was added to the wells. The average of each triplicate was 
calculated, compared with the maximum release control 
and expressed as a percentage using the following formula: 
test cpm - 
% release of test= 
cpm of medium alone 
maximal release cpm - 
cpm of medium alone 
Assessment and Quantifafion of EC Detachment 
Cell detachment from BM was quantified as described 
previously (9). Briefly, the slides bearing the amnionic 
membranes were removed from the chamber, washed 
extensively with PBS, dried in air, then fixed and stained 
using a modified Wright-Giemsa stain (Diff-Quick, 
Medicon, Australia). Detachment was evaluated at low 
power (60 x ) using an eyepiece graticule. The percentage of 
any remaining attached cells to the amnionic BM in the test 
wells was scored on a scale of O-100% in 10% increments. 
Detachment is expressed as 100% attached cells. All slides 
were counted blind by the same blinded observer (TV). 
Repeat counts of randomly selected slides produced identi- 
cal results (~10% difference). As stated previously, this 
method is as accurate as the direct counting of individual 
cells in adjacent high power fields, and has excellent 
correlates with spectrophotometric quantification methods 
reported previously (9). 
Evaluation of Inhibitors 
The next step was to assess which enzymes in the sputum 
or blood PMN samples were responsible for the EC detach- 
ment, and this was carried out using protease inhibitor 
profiles, as evaluated in the authors’ previous study (10). 
The following protease inhibitors and anti-oxidants were 
studied. Phenylmethylsulfonyl fluoride (PMSF; an active 
site directed, irreversible inhibitor of serine proteases) and 
1, lo-phenanthroline (an inhibitor of metalloproteinases) 
were dissolved in 1% dimethyl sulfoxide (DMSO). The 
following inhibitors were dissolved in Gey’s medium: soy- 
bean trypsin inhibitor (SBTI; inhibitor of trypsin and 
chymotrypsin); alpha 1-antitrypsin (al-AT; serine protease 
inhibitor); aprotinin (broad spectrum antiprotease); 
N-acetyl cysteine (NAC) and glutathione (GSH; inhibitors 
of bacterial collagenase and cathepsin G as well as having 
anti-oxidant properties); and ethylenediaminetetraacetic 
acid (EDTA, inhibitor of metalloproteinases). Catalase and 
superoxide dismutase (CAT and SOD; anti-oxidants), SBTI 
type II-S, aprotinin (A-4529); PMSF, l,lO-phenanthroline, 
EDTA, GSH, NAC, CAT and SOD were obtained from 
Sigma and al-AT from Boehringer Mannheim. Inhibitors 
were premixed with the agent being tested in a 96-well, 
conical-bottom tissue culture plate and pre-incubated for 
15 min on ice prior to application onto the amnionic 
membrane installed in the microchemotaxis assembly. In 
this way, four purified enzymes were also tested: human 
sputum cathepsin G at 2.15 x 10’ SAAPP,NA U ml-’ 
(Elastin products company, MO, U.S.A., Cat.#SG45); 
Porcine pancreatic elastase at 92 elastin U ml ~ ’ (Sigma, 
type IV, Cat.#E-0258); C. histolyticum collagenase at 
2 x 10’ ninhydrin U ml- ’ (Sigma, type II, Cat.#C-6885); 
and porcine pancreatic trypsin at 2 x lo3 BAEE U ml ~ ’ 
(Sigma, type IX, Cat.#T-0314). All inhibitors were charac- 
terized by evaluating their inhibition of enzymes at the 
minimum effective concentration of enzyme producing 
100% EC detachment (MEC,,,). That concentration was 
also added to wells containing either sputum samples 
(randomly selected non-CF/infected samples n=4 and CF 
samples n= 5), PA isolates (n= 3) or TPA-activated PMN 
(n=9) to characterize the protease inhibition profile of EC 
detachment induced by these agents. The inhibitors were 
tested alone to ensure they did not contribute to EC 
detachment. None of the inhibitors at the concentrations 
used in the assays caused any EC detachment. 
STATISTICAL ANALYSIS 
The Mann-Whitney non-parametric test was used for 
statistical comparisons performed in Figs 1 and 5. The 
unpaired Student’s alternate t-test (used for small number 
comparisons where the standard deviations of the samples 
are significantly different, i.e. where a normal distribution is 
not assumed) was used for Figs 4 and 6. Two-tailed P 
values are detailed in the legends and symbols are shown in 
the figures. 









Non-CFhon-infected Non-CFhfected CF sputum 
sputum sputum, 
FIG. 1. Effect of non-cystic fibrosis (CF)/non- infected 
(A, n=6), non-CF/infected (0, n=6) and CF (0, n=7) 
sputum samples on epithelial cell detachment following 
overnight incubation at 37°C. Protein concentration for all 
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FIG. 2. Dose-response curves following overnight (37°C) 
exposure of epithelial cells to log dilutions of non-cystic 
fibrosis (CF)/infected sputum (0, n=6); CF sputum 
(0, n=7); Pseudomonas aeruginosa (H, n=3); 
Staphylococcus aureus (A, y2 = 3); and Haemophilus 
influenzae ( V , n = 3). Mean k SEM. 
Results 
CF sputa, incubated overnight with the amnionic EC, 
induced near complete EC detachment, 86.6 f 1.8% for 
n=7 [mean f standard error of the mean (x k SEM)]. Non- 
CF/infected sputum samples induced 66.9 f 7% EC detach- 
ment, which is not significantly less than CF sputum, 
whereas non-CF/non-infected sputum induced an average 
of 14.2 & 12.9% EC detachment which is less than both 
CF sputum (P=O.O012) and non-CF/infected sputum 
(P=O.O26) (Fig. 1). 
When a pure isolate of PA was examined alone, it was 
also capable of inducing similar EC detachment to that 
observed with both CF and non-CF/infected sputum, 
whereas neither HI nor SA induced any EC desquamation 
(Fig. 2). There were no differences observed when the 
damage (5’Cr release) induced on EC by resting or TPA 











FIG. 3. Effect of blood neutrophils isolated from normal 
volunteers (0) or from cystic fibrosis patients (m). Cells 
were added at 5 x lo6 or 10 x lo6 ml- i to the wells in a 
resting state or activated with TPA (100 ng ml - ‘) and 
chambers were incubated overnight at 37°C. Percentage 
epithelial cell (EC) damage (a) and percentage EC 
detachment (b) are shown as mean f SEM for n=7. 
*p<o.o5. 
[Fig. 3(a)]. However, when EC detachment was assessed, 
there was a significant reduction in the ability of resting CF 
blood PMN to detach EC compared .to normal. (P<O.O5), 
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I I I 11 ( ’ II ) 11 ’ 1 
DMSO - - - - + + 
PMSF - - +++ +++ + ++ 
al-AT - - +++ +++ - - 
Phenanthroline - +++ - 
EDTA - +++ - - - - 
Aprotinin - - +++ + + f 
SBTI - +++ - +++ +++ 
GSH - +++ - - ++-t + 
NAC - +++ - - +++ + 
CAT/SOD - ND ND ND ND - 
FIG. 4. Capacity of protease inhibitors to block epithelial cell detachment induced by defined proteases (a), compared with 
non-cystic fibrosis (CF)/infected sputa (0, n=4) and CF sputa (m, n=5) (b). Data in (a) shows the inhibitor profiles of 
collagenase (2 x lo2 ninhydrin U ml- ‘, or 1.5 mmol l- ’ of C. histolyticum collagenase); trypsin (2 x lo3 BAEE U ml- ‘, 
or 0.005 mmol 1 - ’ of porcine pancreatic trypsin); elastase (92 elastin U ml - ‘, or 0.08 mm01 1 - ’ of porcine pancreatic 
elastase); cathepsin G (2.15 x lo3 SAAPPpNA U ml - ‘, or 0.022 mmol 1~ ’ of human sputum cathepsin G); and 
peripheral blood neutrophils at 5 x lo6 ml - ’ activated with TPA (100 ng ml - ‘). The final concentrations of inhibitors 
are as follows: DMSO=l% v/v; PMSF= I mmol l- ‘; al-AT=O.5 mmol l- ‘; l,lO-Phenanthroline= 1 mmol l- ‘; 
EDTA=lmmoll-‘; Aprotinin=O.O3mmolll’; SBT1=0~025mmo1111; GSH=lOmmoll-‘; NAC=lOmmolll’; 
CAT/SOD=0*032 mmol 1~ ‘10.025 mmol l- ‘. ( - , not significant; +, PcO.05; + +, P<O.O25; + + +, P<O.Ol. (b) Shows 
detachment values as a percentage of control (100%). Statistical analysis by unpaired Student’s t-test. *P<O.O5, 
**P<O.O25. 
but when these cells were activated with TPA, they were 
able to induce near total desquamation, comparable to 
normal blood PMN [Fig. 3(b)]. 
As in the authors previous study (lo), the EC de- 
squamative effects of four purified enzymes [collagenase (a 
metalloproteinase), trypsin, elastase, cathepsin G] as well as 
blood PMN were subjected to a panel of inhibitors, reveal- 
ing a distinctive inhibitor profile for each agent, and is 
shown in Fig. 4(a). Control wells containing medium 
alone or medium+inhibitor alone always showed ~5% 
detachment (data not shown). 
Although the elastase used in these defined proteases is 
from porcine pancreas, and has a broader specificity than 
HLE, the literature shows similar inhibition by al-AT and 
other plasma protease inhibitors (14,15). When CF and 
non-CF/infected sputa were subjected to the same panel of 
inhibitors, there were no significant differences between the 
two groups. Importantly, EC detachment induced by 
both groups was highly significantly inhibited by PMSF, 
Aprotinin, SBTI, GSH and NAC, but not by al-AT, 
phenanthroline or EDTA [Fig. 4(b)]. This pattern of 
inhibition is similar to PMN-induced EC detachment as 
shown in Fig. 4(a). When al-AT was tested at increasing 
doses, a lo-fold increase was required to induce significant 
inhibition (Fig. 5). In contrast to the results with sputum, 
the inhibitor profile for PA-induced EC detachment 
exhibited total inhibition by phenanthroline and EDTA, as 
well as highly significant inhibition by GSH and NAC. 
GSH has recently been shown to have anti-metalloprotease 
activity, probably via its glycine moiety (16). There is, 
therefore, evidence to suggest that PA-derived metallopro- 
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FIG. 5. Effect of increasing al-AT concentration on 
non-cystic fibrosis (CF)/infected sputa (0) or CF sputa 
(0) induced epithelial cell detachment following an 
overnight incubation dt 37°C. **P<O.O5). 
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FIG. 6. Capacity of protease inhibitors to block 
Pseudomonas aeruginosa (PA)-induced epithelial cell 
detachment. Dotted line and shaded area=mean & SEM for 
PA with a total protein concentration of 300 pug ml - ‘. 
Data shows detachment values as a percentage of control 
(100%) and expressed as mean f SEM for n=3. Statistical 
analysis using unpaired Student’s t-test. ***P<O.Ol, 
*P<O.O5. (Refer to Fig. 4 legend for inhibitor 
concentrations). 
Discussion 
To prevent the progressive airway damage that occurs in 
CF, a clear understanding of the molecules producing this 
damage is needed. This study has shown that EC detach- 
ment is produced by CF sputum; furthermore, the pattern 
of protease inhibition suggested that PMN-derived rather 
than bacterium-derived proteases were responsible. 
There has been substantial debate regarding the impor- 
tance of either (or both) PA or PMN in inducing the 
epithelial damage seen in CF patients (6,17). Both PA and 
PMN can release a number of proteolytic enzymes which 
are capable of causing direct damage to tissues (2-6). CF 
sputa contain both PA and PMN, and induced considerable 
desquamation of EC in this study compared to non-infected 
sputum samples. The fact that PA, but not HI and SA, 
caused EC detachment suggested that the capacity of 
enzymes produced by the other organisms to damage 
epithelium directly was minimal. However, non-CF sputa 
infected with SA or HI did induce high levels of EC 
desquamation, suggesting that they can indirectly induce 
EC damage by inducing changes in the sputum. As it 
seemed likely that it is the PMN and/or PMN products 
found in these sputum samples which were the cause of EC 
detachment, the authors carried out experiments to assess 
the tissue damaging properties of PMN in this system. In 
particular, the possibility that CF PMN have some inherent 
property, giving them greater capacity to induce EC detach- 
ment, was assessed. This was not the case, as substantial EC 
detachment was found to be induced by both isolates and 
there was no overall difference in their ability to damage or 
detach EC. The observation that non-activated CF PMN 
were less capable of inducing detachment than PMN 
obtained from normal volunteers was unexpected, and 
perhaps related to sequestration of mature, activated PMN 
in the lungs of CF patients, leading to the accumulation of 
less mature PMN from the bone marrow in to the blood- 
stream. These cells, however, were clearly functional in that 
they were able to be activated by TPA to cause detachment 
at levels similar to normal blood PMN. 
In contrast to SA and HI, when PA was tested alone, it 
was able to cause EC detachment. In order, therefore, to 
differentiate between potential bacterial and PMN contri- 
bution to tissue damage, the antiprotease inhibition profiles 
of CF and non-CFlinfected sputa were compared to that of 
PA and PMN. The inhibition profile for both CF sputa and 
non-CFlinfected sputa revealed similar patterns, and 
importantly, this pattern closely paralleled the pattern of 
inhibition for PMN-induced EC detachment in this model, 
particularly implicating cathepsin G. Importantly, it was 
distinctly different from the protease inhibitory profile of 
PA which was that of Pseudomonas elastase, a metallo- 
proteinase, which was inhibited by chelators phen- 
anthroline and EDTA. neither of which had inhibitory 
effects on CF sputa-induced detachment in this study. 
Further support for this is the inhibitory effects of SBTI on 
sputum. This agent is well described as an inhibitor of 
‘chymotrypsin-like’ serine protease enzymes (cathepsin G) 
in purnlent sputum, with a weaker effect on elastase and no 
effect on metalloproteases (18). Both cathepsin G and HLE 
are released from azurophilic granules of PMN. The release 
of azurophilic granule contents has been shown to be 
induced by chemo-attractants (19), fragmented peptides 
such as fibronectin (20) and various other chemicals. It has 
also been shown that azurophilic granule contents are 
usually discharged to the outer environment during ‘frus- 
trated phagocytosis’, a feature likely to occur in CF where 
PMN are unable to engulf alginate-protected PA (21). Both 
cathepsin G and HLE are found in free form in sputum 
samples, and one study showed 96% of total elastase and 
78% of total cathepsin G was unbound to protease inhibi- 
tors (17); the authors suggested an imbalance existed 
between PMN proteases and inhibitors with inactivation of 
inhibitors by PMN enzymes. This is supported by a study 
on al-AT treatment in CF, with suppression of PMN 
elastase activity in epithelium lining fluid being demon- 
strated (22) and by in vitro experiments which showed a 
molar excess of secretory leukocyte protease inhibitor 
(SLPI) was required to inhibit HLE activity (23). There are 
a number of natural antiproteases released in the airways 
by the epithelium (24,25). but these may be overwhelmed 
by leukocyte enzymes. PA itself may contribute to this 
inability to inactivate HLE, and Suter et al. have also 
suggested PMN and PA may act synergistically by 
inactivating al-AT and causing proteolysis of surrounding 
tissues (6). Whilst the present authors could not evaluate 
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this synergism in this study in terms of al-AT degradation, 
their results have added support to the proposal of an 
imbalance between proteases and antiproteases given that a 
IO-fold increase in al-AT concentration was required to 
inhibit sputum-induced detachment. 
Previous studies demonstrated that proteolytic activity in 
the sputum of CF patients was mostly derived from PMN 
rather than PA (26); however, most of these studies used 
in vitro systems such as C3 cleavage and elastolytic activity 
(6). Others have used human bronchial EC monolayers to 
test the effect of PMN and PA elastases, demonstrating a 
loss of tight junctions (27). This research adds to these 
investigations by studying these proteolytic effects on EC 
which are still attached ‘naturally’ to their BM, and are 
not derived from in vitro cultures. The present paper gives 
direct evidence that the activity in CF sputa which 
causes EC detachment from underlying native BM is due to 
PMN enzymes. This model can be used to further investi- 
gate the implications of inflammation in the airways of 
CF patients, and to test the efficacy of various anti- 
proteases, such as SLPI and ICI-200,880, to reduce 
epithelial destruction. 
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